DEVELOPMENT AND COMMERCIALIZATION AGREEMENTDevelopment and Commercialization Agreement • August 5th, 2019 • Pulmatrix, Inc. • Pharmaceutical preparations • Delaware
This DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (together with the schedules and exhibits attached hereto, the “Agreement”) is entered into as of April 15, 2019 (the “Effective Date”) by and between PULMATRIX, INC., a Delaware corporation with its principal place of business in 99 Hayden Avenue, Suite 390, Lexington, Massachusetts 02421, United States of America (the “Company”), and CIPLA TECHNOLOGIES, LLC, a Delaware limited liability company with its principal place of business in 12220, El Camino Real, Ste 310, San Diego, 92130 California, United States of America (“Cipla”). Company and Cipla may each be referred to as a “Party” or, collectively, as the “Parties.”
